{"nctId":"NCT04640038","briefTitle":"Contrast Enhanced Ultrasound in COVID-19","startDateStruct":{"date":"2020-12-18","type":"ACTUAL"},"conditions":["Covid19","Multisystem Inflammatory Syndrome in Children (MIS-C)"],"count":4,"armGroups":[{"label":"Contrast-enhanced Ultrasonography","type":"EXPERIMENTAL","interventionNames":["Drug: Sulfur hexafluoride lipid-type A microspheres"]}],"interventions":[{"name":"Sulfur hexafluoride lipid-type A microspheres","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Patient (male/female) hospitalized at the Children's Hospital of Philadelphia (CHOP).\n2. Patient 17 years of age or younger.\n3. Diagnosis of COVID-19 or high clinical suspicion for COVID-19 despite negative tests (according to the definition of probable case by the European Centre for Disease Prevention and Control).\n4. Patients have evidence of cardiovascular compromise, myocardial injury, acute kidney injury and/or new-onset neurological symptoms.\n5. Parental/guardian permission (informed consent)\n\nExclusion Criteria:\n\n1\\. Medical history of Lumason hypersensitivity","healthyVolunteers":false,"sex":"ALL","minimumAge":"1 Minute","maximumAge":"17 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Estimate the Proportion of Patients With Normal Perfusion Versus Area(s) of Hypoperfusion in Heart, Kidneys and/or Brain","description":"Assess microvascular perfusion of the heart, kidneys and/or brain using CEUS in patients with confirmed or probable diagnosis of COVID-19.\n\nA sufficient diagnostic quality to analyze the ultrasound examination was accomplished in three out of four patients.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":4},"commonTop":[]}}}